Dopamine receptor expression and function in corticotroph pituitary tumors.
about
Treatment of Cushing disease: overview and recent findingsTreatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.Update in the medical therapy of Cushing's diseaseThe Treatment of Cushing's Disease.Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas.Medical treatment of Cushing's disease: Overview and recent findings.Update on medical treatment for Cushing's disease.Clinical Guidelines for the Diagnosis and Treatment of Cushing's Disease in Korea.Treatment Options in Cushing's Disease.Management Strategies for Aggressive Cushing's Syndrome: From Macroadenomas to EctopicsMedical management of Cushing's disease: what is the future?Cushing's Disease: Sustained remission in five cases induced by medical therapy with the dopamine agonist cabergoline.The Role of Isotretinoin Therapy for Cushing's Disease: Results of a Prospective Study.Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine cushing's diseaseEndocrine clinical update: where are we in the therapeutic management of pituitary-dependent hypercortisolism?New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapyCharacterization of persistent and recurrent Cushing's diseaseThe somatostatin receptor subtype 5 in neuroendocrine tumours.Pasireotide for the treatment of Cushing's disease.Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2--clinical implicationsRecent developments in drug therapy for Cushing's disease.Efficacy of medical treatment in Cushing's disease: a systematic review.Molecular basis of pharmacological therapy in Cushing's disease.Managing Cushing's disease: the state of the art.Pituitary-directed medical therapy in Cushing's disease.Emerging drugs for Cushing's disease.Cushing's syndrome: an update on current pharmacotherapy and future directions.Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.Currently used and investigational drugs for Cushing´s disease.Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy.Remission with cabergoline in adolescent boys with Cushing's disease.Expression stability of reference genes for quantitative RT-PCR of healthy and diseased pituitary tissue samples varies between humans, mice, and dogs.Younger age is a risk factor for regrowth and recurrence of nonfunctioning pituitary macroadenomas: Results from a single Australian centre.Pituitary-Directed Therapies for Cushing's Disease.New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A.Síndrome de Nelson: relato de casoDopamine Agonists for Pituitary AdenomasGene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles
P2860
Q24626819-B457EBAC-8CD1-48FE-BA38-5B440DD87646Q24629410-E98DA81D-38BA-4387-A364-FE1257AD1F1CQ26865203-78E8DFA7-D547-4DFF-950D-2F48D31E1233Q27010590-1C28F745-7483-439D-9487-C4C9CF36BB48Q33579615-06FC3F5C-74B4-4F2B-9FFF-588C03BFCC61Q33735039-3DAA478F-1BC8-41E4-A4DB-5DCE86BE3797Q33802284-313C86A0-ACA5-4A86-BD5B-04E07BDE4EBAQ35260959-181D6460-D0A0-4D06-9601-5CA26BA1F1A1Q35740882-36481369-AB03-407B-8AE5-ADFD2D209C8EQ36184067-3B066E72-78DF-4C69-B6B9-BBF1A7265D24Q36236884-97D6E724-8D11-48E7-9CF0-387B6F57ACA2Q36471795-72F89CF5-BC25-40F5-8147-8D6510E06599Q36681083-6809C20F-5898-41BF-9DA0-2140AF9C8DF9Q36908926-E866B559-AE82-48D9-B51F-A6003A990AF3Q36940053-3C57557A-8460-495F-BD48-A9A921EB3970Q37049132-4C4BF3DB-C4C5-4F25-8087-D7566250AF54Q37610803-D11B6BC8-66F5-4DA0-81D5-E32E73413A03Q37691450-B71A6358-D9F0-4E12-9123-D92967C8BC4BQ37763714-E7504B47-E743-4C2F-8632-E98BA4762617Q37772579-6EA3B489-828C-4B7C-B297-22305B0423D7Q38112082-D61EB162-8B48-40FF-8932-E9ED9724AB44Q38151882-289B3FF2-C536-4435-B329-2CE01E54F348Q38165863-71D66413-7B6E-400A-9823-E5FB8249C996Q38177740-5E82DEEB-5E62-448E-A399-FDB1952D83C5Q38334659-622E33C1-F1BF-4784-89E8-6E56776578FBQ38505947-01389CD2-97AB-4AF5-B1C8-87D30F2146C8Q38541695-18399329-F87D-449A-9CB9-9F2685311FA4Q38718807-2FAE9ACF-93FA-4F53-A486-F4B1F6AE55DBQ39022297-0311FB5B-21EB-457F-8C7B-3D50B4EB1E19Q39551743-EE61F697-C32B-4A1A-BF78-6A39FA528F55Q42290533-0D91FC47-3934-4EFA-A1FE-2413DF798C55Q42925500-C143030F-53F7-4617-A602-03CE3EEA93E9Q45204572-3E424BD4-A7A8-4821-9E55-3E330A4D8EF5Q48198971-61F00281-5578-40A6-B41C-8CFACE3F440BQ54961209-EF3A1E1D-2E9D-438F-B4FB-5021C729E722Q55249109-B917F1F9-F005-4F19-9E16-779C2547EECFQ57632615-ADFB3BD0-EEFA-41A0-85AA-7A51E63B9944Q58729410-9AA42D10-B7DF-41BE-92A3-D69B69C87D53Q58796556-DD073E0A-5D17-4052-8EFD-6F2289E7E289
P2860
Dopamine receptor expression and function in corticotroph pituitary tumors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Dopamine receptor expression and function in corticotroph pituitary tumors.
@en
Dopamine receptor expression and function in corticotroph pituitary tumors.
@nl
type
label
Dopamine receptor expression and function in corticotroph pituitary tumors.
@en
Dopamine receptor expression and function in corticotroph pituitary tumors.
@nl
prefLabel
Dopamine receptor expression and function in corticotroph pituitary tumors.
@en
Dopamine receptor expression and function in corticotroph pituitary tumors.
@nl
P2093
P50
P356
P1476
Dopamine receptor expression and function in corticotroph pituitary tumors.
@en
P2093
Diego Ferone
Johan M Kros
Leo J Hofland
Lucio Annunziato
Maria Laura Del Basso De Caro
Marica Arvigo
Steven W J Lamberts
P304
P356
10.1210/JC.2003-030837
P407
P577
2004-05-01T00:00:00Z